MedTrace Logo

Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)

NCT00842387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2370

Last updated 2009-12-23

No results posted yet for this study

Summary

The aim of this project is to compare the GERD clinical outcomes in patients where a structured pathway using the GerdQ questionnaire is implemented compared with the clinical outcomes of those treated without this implementation.

This is a European project with 5 participating countries (Austria, Italy, Norway, Spain and Sweden). Due to different characteristics regarding the actual management of this disease in the 5 countries, each country had the flexibility to introduce design differences and changes in the study protocol.

Conditions

  • Reflux
  • Heartburn
  • Regurgitation
  • Esophagitis

Sponsors & Collaborators

Principal Investigators

  • Mónica Tafalla, MD · Medical DepartmentAstraZeneca Spain

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Completion
2009-12-31

Countries

  • Austria
  • Italy
  • Norway
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00842387 on ClinicalTrials.gov